Related topics: radiation oncology ยท lung cancer

Nanoparticles for lung cancer pass next test

The most common type of lung cancer, non-small cell lung cancer (NSCLC), continues to be difficult to treat, with five year survival rates of about 36 percent for stage 3A tumors. Jefferson College of Pharmacy researchers ...

Versatile sensor against tumor initiating cells

Most cancer deaths are caused by recurrent or metastatic tumors. Conventional therapies target rapidly dividing tumor cells, but are unable to eradicate the highly chemoresistant tumor initiating cells (TICs), ultimately ...

Deadly nanoparcel for cancer cells

Most tumors contain regions of low oxygen concentration where cancer therapies based on the action of reactive oxygen species are ineffective. Now, American scientists have developed a hybrid nanomaterial that releases a ...

How nanotechnology could detect and treat cancer

A growing field called nanotechnology is allowing researchers to manipulate molecules and structures much smaller than a single cell to enhance our ability to see, monitor and destroy cancer cells in the body.

page 1 from 2